{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "At a CAGR of 11.7%, Global Respiratory Syncytial Virus (RSV) Therapeutics Market Will Rise in the Period of 2017-2025: Merck & Co, AstraZeneca, ReViral",
    "author_name": "Researchmoz Global Pvt. Ltd.",
    "author_url": "http:\/\/www.researchmoz.us\/"
}